Projectes destacats

  • Tailored immunotherapies in 3D models of Follicular Lymphoma (TAIFOL)

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: Janssen Pharmaceuticals ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundació La Marató de TV3 .
    Durada: 01/04/2020
  • Characterization of duvelisib activity in follicular lymphoma and macrophages crosstalk

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: Janssen Pharmaceuticals ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Verastem .
    Durada: 01/01/2020 - 31/12/2020
  • Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET

    Investigador/a principal: Patricia Pérez Galán, Maria Cinta Cid Xutgla, Patricia Pérez Galán.
    Finançador: Ministerio de Economia y Competitividad (MINECO) (Patrocinador).
    Codi: SAF 2017- 88275-R.
    Durada: 01/01/2018 - 31/12/2020
  • Cross-border network of personalized immunotherapies in Non-Hodgkin Lymphoma -IMLINFO (POCTEFA-INTERREG). Proyecto financiado por Fondo Europeo de Desarrollo Regional (FEDER)

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: INTERREG V-POCTEFA .
    Codi: EFA281/16.
    Durada: 01/01/2018 - 31/12/2021
  • MICROENTARGET: Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention.

    Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); MINECO .
    Durada: 01/12/2017
  • Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Ministerio de Economia y Competitividad (MINECO) ; PROYECTOS I+D+I RETOS INVESTIGACIÓN (Programa financiador competitivo).
    Codi: SAF2014-57708-R.
    Durada: 01/10/2015 - 30/09/2018
  • Characterization of the mechanisms of microenvironment-derived resistance to GS-1101/ Idelalisib in follicular lymphoma. Analysis of therapeutic potential combination with other kinases inhibitors

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: Gilead .
    Durada: 01/07/2014
  • HuMax-CD38 (Daratumumab) activity in in vivo models of MCL and FL: Analysis of possible combinatorial regimens

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Janssen Pharmaceuticals .
    Durada: 01/06/2014
  • Targeting proliferation and tumor-microenvironment interactions using bifunctional compounds against cannabinoid and chemokine receptors

    Investigador/a principal: Patricia Pérez Galán.
    Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundacio la Marato TV3 ; http://www.tv3.cat/marato/es/projectes_financats_2012 (Programa financiador competitivo).
    Durada: 26/05/2014 - 26/05/2017
  • Microenvironment Interactions in the pathogenesis of lymphoid neoplasms and chronic inflammatory disorders. Identification of biomarkers and design of new therapeutic strategies

    Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos III ; Proyectos transversales ISCIII (Programa financiador competitivo).
    Codi: PIE1313/00033.
    Durada: 01/03/2014 - 01/03/2017